Jesse Solomon
  1. Partner

Mr. Solomon is a partner in Davis Polk’s Litigation Department, practicing in the Washington DC office.  Named a “next-generation lawyer” by Legal 500 U.S. and nominated by Global Competition Review as 2018’s “Lawyer of the Year (Under 40),” Mr. Solomon regularly advises clients on the competition law aspects of complex and high-profile mergers, acquisitions, and joint ventures.  In that vein, he frequently develops global strategies for obtaining competition clearance of transactions across international jurisdictions, with particular experience in transactions in the healthcare, pharmaceuticals, chemicals, and consumer products industries.  He also routinely represents clients in antitrust investigations of transactions and conduct matters before the Federal Trade Commission and the U.S. Department of Justice.  

Work Highlights

Selected Antitrust Representations
  • Aetna Inc. on its pending $77B sale to CVS Health
  • Syngenta in:
    • ChemChina’s pending $43 billion acquisition of the company
    • Its successful defense of a takeover proposal by Monsanto 
  • Fibria on its pending $11B sale to Suzano
  • PricewaterhouseCoopers on its sale of its public sector government consulting practice
  • Uniti Group on the divestiture purchase of assets sold by CenturyLink in connection with its acquisition of Level 3
  • General Electric in numerous transactions relating to the sale of GE Capital lending units
  • Manhattan Beer in its $250 million acquisition of Windmill Distributing’s beer brand distribution rights
  • ConAgra in the $2.7 billion sale of its private brands business to TreeHouse Foods
  • Smith & Nephew in connection with its $1.7 billion acquisition of ArthroCare
  • AstraZeneca:
    • On the U.S. antitrust aspects of the $119 billion acquisition proposal by Pfizer
    • In its $1.15 billion acquisition of Pearl Therapeutics
  • Tyson Foods in its $8.55 billion acquisition of Hillshire Brands
  • BATS Global Markets in its acquisition of Direct Edge
  • CVS Caremark in its $1.25 billion acquisition of the Medicare prescription drug business of Universal American
  • Comcast in its $37.25 billion joint venture with NBCUniversal
  • Equinix in its $689 million acquisition of Switch and Data
Other Notable Matters
  • The board of directors of Direct Edge in connection with an SEC multidisciplinary inquiry relating to potential violations concerning technology, information security, securities compliance and governance

Recognition

 Mr. Solomon is consistently recognized as a lead in the legal industry:

  • The Legal 500 U.S.  –  "Next-Generation Lawyer: Antitrust Merger Control," 2018
  • Global Competition Review  –  "Lawyer of the Year (Under 40)" Nominee, 2018
  • Antitrust Writing Awards  –  "Best Academic Asian Antitrust Article," 2017
  • Antitrust Writing Awards  – "Best Business Asian Antitrust Article," 2017
  • The Burton Awards for Legal Achievement  –  "Distinguished Legal Writing Award," 2013
  • Antitrust Writing Awards – "Best Academic Mergers Article," 2013

Of Note

  • Associate Editor, Antitrust Law Journal
  • Author of articles for a variety of antitrust publications, including Antitrust Magazine, Concurrences, and numerous American Bar Association publications
  • Member, Section of Antitrust Law, American Bar Association

Professional History

  • Davis Polk since 2008
  • Partner, 2016-present
  • Northern California office, 2008-2010
  • Washington DC office, 2010-present

Bar Admissions

  • District of Columbia
  • State of California
  • U.S. Supreme Court
  • U.S. Court of Appeals, D.C. Circuit
  • U.S. District Court, N.D. California
  • U.S. District Court, District of Columbia

Education

  • B.A., English Literature, Emory University, 2001
    • Phi Beta Kappa
    • Robert W. Woodruff Scholar
    • summa cum laude
  • M.A., English Literature, Emory University, 2001
    • summa cum laude
  • J.D., UC Berkeley School of Law, 2008
    • Order of the Coif
    • Senior Notes and Comments Editor, California Law Review

Languages

  • French